Mechanistic understanding of human SLFN11.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 09 2022
Historique:
received: 01 04 2022
accepted: 01 09 2022
entrez: 17 9 2022
pubmed: 18 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Schlafen 11 (SLFN11) is an interferon-inducible antiviral restriction factor with tRNA endoribonuclease and DNA binding functions. It is recruited to stalled replication forks in response to replication stress and inhibits replication of certain viruses such as the human immunodeficiency virus 1 (HIV-1) by modulating the tRNA pool. SLFN11 has been identified as a predictive biomarker in cancer, as its expression correlates with a beneficial response to DNA damage inducing anticancer drugs. However, the mechanism and interdependence of these two functions are largely unknown. Here, we present cryo-electron microscopy (cryo-EM) structures of human SLFN11 in its dimeric apoenzyme state, bound to tRNA and in complex with single-strand DNA. Full-length SLFN11 neither hydrolyses nor binds ATP and the helicase domain appears in an autoinhibited state. Together with biochemical and structure guided mutagenesis studies, our data give detailed insights into the mechanism of endoribonuclease activity as well as suggestions on how SLFN11 may block stressed replication forks.

Identifiants

pubmed: 36115853
doi: 10.1038/s41467-022-33123-0
pii: 10.1038/s41467-022-33123-0
pmc: PMC9482658
doi:

Substances chimiques

Antineoplastic Agents 0
Antiviral Agents 0
Apoenzymes 0
Nuclear Proteins 0
SLFN11 protein, human 0
Adenosine Triphosphate 8L70Q75FXE
DNA 9007-49-2
Interferons 9008-11-1
RNA, Transfer 9014-25-9
Endoribonucleases EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5464

Informations de copyright

© 2022. The Author(s).

Références

Nat Methods. 2019 Nov;16(11):1153-1160
pubmed: 31591578
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Nat Commun. 2021 Jul 16;12(1):4375
pubmed: 34272366
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15030-5
pubmed: 22927417
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Sci Transl Med. 2020 Feb 19;12(531):
pubmed: 32075943
Curr Opin Struct Biol. 2010 Jun;20(3):313-24
pubmed: 20456941
Nucleic Acids Res. 2012 Aug;40(14):e112
pubmed: 22539264
J Virol. 2019 Jul 17;93(15):
pubmed: 31118262
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nucleic Acids Res. 2022 Jan 25;50(2):1147-1161
pubmed: 35037067
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
Clin Cancer Res. 2017 Jan 15;23(2):523-535
pubmed: 27440269
Nat Struct Mol Biol. 2018 Nov;25(11):1047-1058
pubmed: 30374083
Cell Rep. 2020 Mar 24;30(12):4137-4151.e6
pubmed: 32209474
Oncotarget. 2016 Nov 22;7(47):76534-76550
pubmed: 27708213
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35105802
J Biol Chem. 2019 Oct 4;294(40):14674-14685
pubmed: 31395656
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33536335
Nat Commun. 2018 Mar 21;9(1):1165
pubmed: 29563550
RNA. 2018 Jul;24(7):939-949
pubmed: 29678925
Adv Exp Med Biol. 2013;767:17-46
pubmed: 23161005
J Thorac Oncol. 2020 May;15(5):843-859
pubmed: 32004714
Clin Cancer Res. 2019 Oct 15;25(20):6206-6216
pubmed: 31409613
Nat Commun. 2020 Oct 15;11(1):5208
pubmed: 33060581
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
PLoS Pathog. 2016 Dec 27;12(12):e1006066
pubmed: 28027315
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2564-9
pubmed: 27114506
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Nat Commun. 2021 Oct 27;12(1):6204
pubmed: 34707099
Anticancer Res. 2019 Jul;39(7):3553-3563
pubmed: 31262879
J Struct Biol. 2021 Jun;213(2):107702
pubmed: 33582281
Science. 2021 May 14;372(6543):
pubmed: 33986151
Biochemistry. 2015 Jun 2;54(21):3286-301
pubmed: 25996083
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Viruses. 2022 Feb 21;14(2):
pubmed: 35216035
Br J Cancer. 2021 Mar;124(5):951-962
pubmed: 33339894
Anal Biochem. 2003 Oct 15;321(2):266-71
pubmed: 14511695
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Oncotarget. 2017 Apr 25;8(17):28575-28587
pubmed: 28212573
Pharmacol Ther. 2019 Sep;201:94-102
pubmed: 31128155
Acta Biochim Pol. 2016;63(4):737-744
pubmed: 27741327
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):519-530
pubmed: 29872003
Mol Cell. 2018 Feb 1;69(3):371-384.e6
pubmed: 29395061
Nucleic Acids Res. 1994 Sep;22(17):3578-80
pubmed: 7937062
Nat Methods. 2020 Dec;17(12):1214-1221
pubmed: 33257830
Nature. 2012 Nov 1;491(7422):125-8
pubmed: 23000900
EMBO Rep. 2016 Jan;17(1):94-109
pubmed: 26658330
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Oncotarget. 2016 Jan 19;7(3):3084-97
pubmed: 26625211
Front Oncol. 2019 Oct 01;9:994
pubmed: 31632920

Auteurs

Felix J Metzner (FJ)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Simon J Wenzl (SJ)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Michael Kugler (M)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Stefan Krebs (S)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Karl-Peter Hopfner (KP)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany.

Katja Lammens (K)

Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 25, 81377, Munich, Germany. klammens@genzentrum.lmu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH